Aipedia: Aesthetics clinics

AI social media content and the Botox ad ban

Aipedia, by the Apex broking team · Last reviewed 2026-10-27

AI-written social posts that mention Botox, even only in a hashtag, are likely to be treated as illegal advertising of a prescription-only medicine. For prescribers the consequences can reach their professional regulator, not just the ASA.

Part of: AI in aesthetics clinics

In short

Clinics use AI tools to write captions, hashtags and post schedules. These tools may optimise for reach and add popular terms such as Botox or anti-wrinkle injections. CAP rule 12.12 bans advertising prescription-only medicines to the public, and CAP advice from 29 October 2025 says almost any public Botox reference, including hashtags, is likely to be an implied POM ad. Doctors must follow CAP under GMC paras 47 to 49, and nurses must use digital communication responsibly under NMC Code 20.10. Advertising breaches are usually outside aesthetic malpractice cover.

How AI creeps into clinic social media

Generative AI tools draft captions from a short prompt, suggest trending hashtags, rewrite reviews into posts and schedule content across platforms. Some clinics may hand this to a junior team member or an agency. The tools do not know UK advertising law. Asked to promote a "tweakments" offer, a tool may add a toxin brand name, a price for toxin treatment, a "no downtime" claim or a hashtag that a human would have avoided. Because posts go out at volume, a single prompt can create dozens of breaches.

The rules that apply

CAP rule 12.12: prescription-only medicines cannot be advertised to the public. Botulinum toxin is a POM.
CAP advice (29 October 2025): the ASA and CAP advice on botulinum toxin says almost any reference to Botox in non-broadcast or social media marketing, including hashtags, is likely to be an implied POM ad. Clinics can promote consultations, not the medicine.
Professional codes: GMC cosmetic guidance paras 47 to 49 require doctors to follow CAP, publish verifiable information and not claim treatments are risk free. NMC Code 20.10 requires nurses to use digital communication responsibly; HCPC standard 9.3 and GMC Domain 4 require communications to be accurate and not misleading.
Under-18s: targeting or appealing to young audiences raises social responsibility issues, and administering toxin or fillers to under-18s for cosmetic purposes is an offence under the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021.

Enforcement history

The ASA has upheld complaints about Botox promotion on social media a number of times, including Venus Beauty Lounge (2015), Beauty Boutique Aesthetics (2019), Faces by AKJ Aesthetics (2019) and Menar Jimmy Georgiou (2023). Upheld rulings are published, and repeat or wide-scale breaches can lead to further ASA sanctions. For a registrant, the ruling can also be evidence in a professional regulator's inquiry into whether marketing met their code. Saying the AI wrote the post is unlikely to help: the clinic and its registrants publish the ad.

What can go wrong

Illustrative scenario: a nurse prescriber runs a small clinic and uses an AI scheduling tool to post daily content. The tool adds a toxin hashtag and the phrase "risk-free wrinkle relaxing" to a month of posts. A member of the public complains. The ASA upholds the complaint, and the nurse then faces questions from the NMC about responsible use of digital communication and promotion of a prescription-only medicine.

The same pattern can appear with AI tools that turn patient reviews into posts. A review that names the medicine, praises a "painless" treatment or describes a result as guaranteed becomes the clinic's own advertising once it is republished, and the clinic must be able to substantiate every claim in it. Tools that reply automatically to comments can also name products or answer questions about doses in public, which turns a customer service reply into promotion of a POM.

How PI usually responds

Aesthetic malpractice and treatment-risk cover is designed for injury arising from treatment. ASA investigations, withdrawn campaigns and lost bookings are not usually covered losses. Some policies for registrants include regulatory defence costs for fitness to practise proceedings, which may extend to a marketing allegation; others limit this to clinical matters. Fines and penalties are generally not insurable. Agencies that create posts for clinics need their own professional indemnity. See prescriber cover for toxins and fillers and AI insurance for marketing agencies.

Practical controls

Add a banned-terms list to every AI prompt: toxin brand names, "anti-wrinkle injections", prices for POMs.
Strip hashtags before posting and review them by hand.
Promote consultations and outcomes in general terms, not the medicine.
Have a registrant approve scheduled content, including agency posts.
Audit past posts and remove non-compliant ones.
Keep a record of approvals in case of an ASA or regulator inquiry.

How Apex helps

Apex arranges indemnity for prescribers and aesthetics clinics. A broker can check whether your policy includes regulatory defence costs for marketing complaints.

Sources

Frequently asked

Can I use the word Botox in a hashtag?

CAP advice of 29 October 2025 says almost any public reference to Botox in social media marketing, including hashtags, is likely to be an implied advert for a prescription-only medicine, which breaches CAP rule 12.12.

Who is responsible if an AI tool wrote the post?

The clinic and any registrant who published or approved it. The ASA judges the ad, not how it was produced, and professional regulators expect registrants to ensure marketing complies with CAP.

Does my insurance cover an NMC or GMC investigation over marketing?

It depends on the wording. Some registrant policies include regulatory defence costs that could extend to a marketing allegation; others are limited to clinical matters. Fines are generally not insurable.

Check your indemnity covers how you use AI

Tell us about your practice and the work you do. A broker will review how your current cover treats AI-assisted work, or arrange new cover. No fee for a quote. Or call 0117 325 0027.

Start an indemnity quote Request a callback

Apex Insurance Brokers Limited is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales, company number 07014570. This page is general information about how AI is used in the profession and how insurance may respond. It is not legal, regulatory or insurance advice on your circumstances, and it does not guarantee that cover will be available or on what terms.